Additionally, your coach will share meal plans, grocery guides, and other helpful information
When counseling patients concerned about access or cost following Medicare coverage changes, clinicians can use real-world data like this to reinforce that the therapeutic value of GLP-1s is well-documented, and that exploring alternative coverage pathways or manufacturer assistance programs is worth pursuing before discontinuing therapy
You want to get on good habits, so use it to get good habits
Clinical Evidence: Blood Pressure Reductions in GLP-1 Trials The LEADER trial, which followed over 9,000 people taking liraglutide (a similar GLP-1 drug), documented average systolic blood pressure drops of 23 mmHg within the first weeks of treatment
257(1): 625 Ganapathy V, Huang W, Rajan DP, et al
This depends on the patient what size, number, and darkness of lesions were treating, and the patients risk for pigmentation changes with each treatment